Medical research

A project to develop technology that could improve outcomes for people with kidney disease received a boost, following a £1 million grant.

The first paper describing this now world-leading class of therapeutics was published in August 1985. Since then, the UK Medical Research Council has received more than £580M in royalties

An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.

The collaboration aims to enhance disease understanding and increase the pace of discovery of new therapeutics

Scientists at Sweden’s Karolinska Institutet have managed to build a fully functional neuron by using organic bioelectronics. This artificial neuron contain no ‘living’ parts, but is capable of mimicking the function of a human nerve cell and communicate in the same way as our own neurons do.

The BEAM Alliance – Biotechs from Europe innovating in Antimicrobial Resistance - brings together 37 companies from ten countries to accelerate progress in dealing with drug-resistant infections

Shortcomings in the framework for clinical trials, little knowledge of intellectual property law and an awkward relationship between scientists and technology transfer offices are holding back science-industry collaboration, but work is in hand to change things

Dario Polli, a 38-year old researcher and lecturer at the Physics department of Politecnico di Milano, has been awarded a grant from the European Research Council. His project aims at developing an innovative laser microscopy system for monitoring cancer cells.

Europe’s €3B Innovation Medicines Initiative faced scrutiny over pharma companies’ contributions to the programme in the European Parliament this week – and passed the test.

Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies.